Literature DB >> 26912627

Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.

Ruklanthi de Alwis1, Derek J Bangs1, Michael A Angelo1, Cristhiam Cerpas2, Anira Fernando3, John Sidney1, Bjoern Peters1, Lionel Gresh4, Angel Balmaseda2, Aruna D de Silva1,3, Eva Harris5, Alessandro Sette1, Daniela Weiskopf6.   

Abstract

UNLABELLED: Dengue disease is a large public health problem that mainly afflicts tropical and subtropical regions. Understanding of the correlates of protection against dengue virus (DENV) is poor and hinders the development of a successful human vaccine. The present study aims to define DENV-specific CD8(+)T cell responses in general and those of HLA alleles associated with dominant responses in particular. In human blood donors in Nicaragua, we observed a striking dominance of HLA B-restricted responses in general and of the allele B*35:01 in particular. Comparing these patterns to those in the general population of Sri Lanka, we found a strong correlation between restriction of the HLA allele and the breadth and magnitude of CD8(+)T cell responses, suggesting that HLA genes profoundly influence the nature of responses. The majority of gamma interferon (IFN-γ) responses were associated with effector memory phenotypes, which were also detected in non-B*35:01-expressing T cells. However, only the B*35:01 DENV-specific T cells were associated with marked expression of the programmed death 1 protein (PD-1). These cells did not coexpress other inhibitory receptors and were able to proliferate in response to DENV-specific stimulation. Thus, the expression of particular HLA class I alleles is a defining characteristic influencing the magnitude and breadth of CD8 responses, and a distinct, highly differentiated phenotype is specifically associated with dominant CD8(+)T cells. These results are of relevance for both vaccine design and the identification of robust correlates of protection in natural immunity. IMPORTANCE: Dengue is an increasingly significant public health problem as its mosquito vectors spread over greater areas; no vaccines against the virus have yet been approved. An important step toward vaccine development is defining protective immune responses; toward that end, we here characterize the phenotype of the immunodominant T cell responses. These DENV-reactive T cells express high levels of the receptor programmed death 1 protein (PD-1), while those from disease-susceptible alleles do not. Not only does this represent a possible correlate of immunodominance, but it raises the hypothesis that PD-1 might be a regulator that prevents excessive damage while preserving antiviral function. Further, as this study employs distinct populations (Nicaraguan and Sri Lankan donors), we also confirmed that this pattern holds despite geographic and ethnic differences. This finding indicates that HLA type is the major determinant in shaping T cell responses.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26912627      PMCID: PMC4836325          DOI: 10.1128/JVI.02892-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

Review 1.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

2.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

3.  CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.

Authors:  Raphaël M Zellweger; William W Tang; William E Eddy; Kevin King; Marisa C Sanchez; Sujan Shresta
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

Review 4.  Role of PD-1 in regulating acute infections.

Authors:  Keturah E Brown; Gordon J Freeman; E John Wherry; Arlene H Sharpe
Journal:  Curr Opin Immunol       Date:  2010-04-27       Impact factor: 7.486

5.  The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus.

Authors:  Maya F Kotturi; Bjoern Peters; Fernando Buendia-Laysa; John Sidney; Carla Oseroff; Jason Botten; Howard Grey; Michael J Buchmeier; Alessandro Sette
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

6.  The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.

Authors:  Rama S Akondy; Nathan D Monson; Joseph D Miller; Srilatha Edupuganti; Dirk Teuwen; Hong Wu; Farah Quyyumi; Seema Garg; John D Altman; Carlos Del Rio; Harry L Keyserling; Alexander Ploss; Charles M Rice; Walter A Orenstein; Mark J Mulligan; Rafi Ahmed
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

7.  Original antigenic sin in dengue.

Authors:  S B Halstead; S Rojanasuphot; N Sangkawibha
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

8.  Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.

Authors:  Lukas Baitsch; Amandine Legat; Leticia Barba; Silvia A Fuertes Marraco; Jean-Paul Rivals; Petra Baumgaertner; Céline Christiansen-Jucht; Hanifa Bouzourene; Donata Rimoldi; Hanspeter Pircher; Nathalie Rufer; Maurice Matter; Olivier Michielin; Daniel E Speiser
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

9.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

10.  Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome.

Authors:  Thi Phuong Lan Nguyen; Mihoko Kikuchi; Thi Que Huong Vu; Quang Ha Do; Thi Thuy Tran; Dinh Tham Vo; Manh Tuan Ha; Van Tuong Vo; Thi Phi Nga Cao; Van Dat Tran; Toshifumi Oyama; Kouichi Morita; Michio Yasunami; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2008-10-01
View more
  36 in total

Review 1.  Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine?

Authors:  Jinsheng Wen; Sujan Shresta
Journal:  Curr Opin Immunol       Date:  2019-03-15       Impact factor: 7.486

2.  Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles.

Authors:  Yuan Tian; Mariana Babor; Jerome Lane; Grégory Seumois; Shu Liang; N D Suraj Goonawardhana; Aruna D De Silva; Elizabeth J Phillips; Simon A Mallal; Ricardo da Silva Antunes; Alba Grifoni; Pandurangan Vijayanand; Daniela Weiskopf; Bjoern Peters; Alessandro Sette
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

Review 3.  T Cell Immunity to Zika and Dengue Viral Infections.

Authors:  Jinsheng Wen; Sujan Shresta
Journal:  J Interferon Cytokine Res       Date:  2017-11       Impact factor: 2.607

4.  Human CD4+ T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity.

Authors:  Michael A Angelo; Alba Grifoni; Patrick H O'Rourke; John Sidney; Sinu Paul; Bjoern Peters; Aruna D de Silva; Elizabeth Phillips; Simon Mallal; Sean A Diehl; Beth D Kirkpatrick; Stephen S Whitehead; Anna P Durbin; Alessandro Sette; Daniela Weiskopf
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

5.  Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8+ T Cells.

Authors:  Alba Grifoni; Priscilla Costa-Ramos; John Pham; Yuan Tian; Sandy L Rosales; Grégory Seumois; John Sidney; Aruna D de Silva; Lakshmanane Premkumar; Matthew H Collins; Mars Stone; Phillip J Norris; Claudia M E Romero; Anna Durbin; Michael J Ricciardi; Julie E Ledgerwood; Aravinda M de Silva; Michael Busch; Bjoern Peters; Pandurangan Vijayanand; Eva Harris; Andrew K Falconar; Esper Kallas; Daniela Weiskopf; Alessandro Sette
Journal:  J Immunol       Date:  2018-11-09       Impact factor: 5.422

6.  T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection.

Authors:  Marcela Helena Gonçalves Pereira; Maria Marta Figueiredo; Camila Pereira Queiroz; Télcia Vasconcelos Barros Magalhães; Adriana Mafra; Lilian Martins Oliveira Diniz; Último Libânio da Costa; Kenneth J Gollob; Lis Ribeiro do Valle Antonelli; Helton da Costa Santiago
Journal:  Immunology       Date:  2020-04-06       Impact factor: 7.397

7.  Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.

Authors:  Bobby Brooke Herrera; Wen-Yang Tsai; Charlotte A Chang; Donald J Hamel; Wei-Kung Wang; Yichen Lu; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

8.  HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses.

Authors:  Daniela Weiskopf; Michael A Angelo; Alba Grifoni; Patrick H O'Rourke; John Sidney; Sinu Paul; Aruna D De Silva; Elizabeth Phillips; Simon Mallal; Sunil Premawansa; Gayani Premawansa; Ananda Wijewickrama; Bjoern Peters; Alessandro Sette
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

Review 9.  Immune Response to Dengue and Zika.

Authors:  Annie Elong Ngono; Sujan Shresta
Journal:  Annu Rev Immunol       Date:  2018-01-18       Impact factor: 28.527

10.  Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.

Authors:  Alba Grifoni; John Pham; John Sidney; Patrick H O'Rourke; Sinu Paul; Bjoern Peters; Sheridan R Martini; Aruna D de Silva; Michael J Ricciardi; Diogo M Magnani; Cassia G T Silveira; Alvino Maestri; Priscilla R Costa; Luzia Maria de-Oliveira-Pinto; Elzinandes Leal de Azeredo; Paulo Vieira Damasco; Elizabeth Phillips; Simon Mallal; Aravinda M de Silva; Matthew Collins; Anna Durbin; Sean A Diehl; Cristhiam Cerpas; Angel Balmaseda; Guillermina Kuan; Josefina Coloma; Eva Harris; James E Crowe; Mars Stone; Phillip J Norris; Michael Busch; Hector Vivanco-Cid; Josephine Cox; Barney S Graham; Julie E Ledgerwood; Lance Turtle; Tom Solomon; Esper G Kallas; David I Watkins; Daniela Weiskopf; Alessandro Sette
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.